MURA: Mural Oncology plc Stock

by  •  • Comments Off on MURA: Mural Oncology plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 64.81
Enterprise Value ($M) -206.04
Book Value ($M) 263.82
Book Value / Share 15.59
Price / Book 0.25
NCAV ($M) 239.41
NCAV / Share 14.15
Price / NCAV 0.27

Profitability (mra)
Return on Invested Capital (ROIC) -0.74
Return on Assets (ROA) -7.00
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 9.56
Current Ratio 9.56

Balance Sheet (mrq) ($M)
Current Assets 277.34
Assets 301.75
Liabilities 37.93
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -196.24
Net Income -207.45

Cash Flow Statement (mra) ($M)
Cash From Operations -194.25
Cash from Investing -3.45
Cash from Financing 468.81

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-04 13G/A Westfield Capital Management Co Lp 9.15 -22.03
02-14 13G Armistice Capital, Llc 9.93
02-13 13G/A Vanguard Group Inc 9.13
02-02 13G BlackRock Inc. 7.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-12-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 11,106 101,024 10.99
2024-05-02 13,584 43,461 31.26
2024-05-01 18,911 37,108 50.96
2024-04-30 13,190 41,501 31.78

(click for more detail)

Similar Companies
MORF – Morphic Holding, Inc. MRNS – Marinus Pharmaceuticals, Inc.
MRUS – Merus N.V. NAII – Natural Alternatives International, Inc.
NAMS – NewAmsterdam Pharma Company N.V.


Financial data and stock pages provided by
Fintel.io